- Home
- PHR
PHR
Phreesia Inc.
as 10-13-2025 3:54pm EST
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 1.6B | IPO Year: | 2019 |
| Target Price: | $33.73 | AVG Volume (30 days): | 825.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.42 | EPS Growth: | N/A |
| 52 Week Low/High: | $17.07 - $32.76 | Next Earning Date: | 09-04-2025 |
| Revenue: | $449,672,000 | Revenue Growth: | 15.31% |
| Revenue Growth (this year): | 14.98% | Revenue Growth (next year): | 12.12% |
Stock Insider Trading Activity of Phreesia Inc. (PHR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Linetsky David | PHR | President, Network Solutions | Sep 18 '25 | Sell | $23.94 | 93 | $2,226.30 | 9,883 | |
| Linetsky David | PHR | President, Network Solutions | Sep 17 '25 | Sell | $23.50 | 1,064 | $25,004.00 | 9,883 | |
| Hoffman Allison C | PHR | General Counsel & Secretary | Sep 17 '25 | Sell | $23.50 | 2,059 | $48,386.50 | 136,978 | |
| VanDuyn Amy Beth | PHR | SVP, Human Resources | Sep 16 '25 | Sell | $23.28 | 1,762 | $41,027.11 | 112,479 | |
| Roberts Evan | PHR | President, Provider Solutions | Sep 16 '25 | Sell | $23.28 | 3,761 | $87,572.63 | 726,837 | |
| Linetsky David | PHR | President, Network Solutions | Sep 16 '25 | Sell | $23.28 | 2,165 | $50,410.73 | 9,883 | |
| Hoffman Allison C | PHR | General Counsel & Secretary | Sep 16 '25 | Sell | $23.28 | 3,133 | $72,950.03 | 136,978 | |
| Indig Chaim | PHR | Chief Executive Officer | Sep 16 '25 | Sell | $23.28 | 6,328 | $147,343.68 | 1,255,771 | |
| Gandhi Balaji | PHR | Chief Financial Officer | Sep 16 '25 | Sell | $23.28 | 4,183 | $97,398.65 | 99,125 | |
| Hui Yvonne | PHR | Principal Accounting Officer | Sep 16 '25 | Sell | $23.28 | 940 | $21,887.34 | 30,638 |
Latest Phreesia Inc. News
PHR Breaking Stock News: Dive into PHR Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling
Business Wire
13 days ago
Phreesia Named to TIME’s 2025 List of the World’s Top HealthTech Companies
Simply Wall St.
a month ago
Phreesia Second Quarter 2026 Earnings: EPS Beats Expectations
GuruFocus.com
a month ago
Phreesia Inc (PHR) Q2 2026 Earnings Call Highlights: Record Revenue and First Positive Net Income
Motley Fool
a month ago
Phreesia PHR Q2 2026 Earnings Call Transcript
Zacks
a month ago
Phreesia (PHR) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks
a month ago
Phreesia (PHR) Q2 Earnings and Revenues Beat Estimates
Associated Press Finance
a month ago
Phreesia: Fiscal Q2 Earnings Snapshot
Compare PHR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PHR Phreesia Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.